Theracos
Jeffrey McGroarty is the Chief Financial Officer at TheracosBio since January 2023. Prior to this role, McGroarty held the same position at Annovis Bio, Inc. from April 2019 to September 2022. Their previous experience includes senior roles at Safeguard Scientifics, Exide Technologies, and PricewaterhouseCoopers. McGroarty holds a BS in Accounting from Penn State University and an MBA from The Wharton School.
This person is not in any teams
This person is not in any offices
Theracos
Theracos Inc., a pharmaceutical research and development company, supports research programs in inflammation, metabolism and depression.